Several major European chemical firms face possible debarment by the World Bank following allegations they colluded to overcharge a bank-funded antimalaria program in India.
The firms, along with a number of other Indian and European companies, also face possible punishment from the government of India based on a review of World Bank programs in India by the bank's "institutional integrity" unit, India's top health official said in an interview. "If there's any sort of proof, we are going to take action," Joint Secretary for Health B.K. Prasad said.
Well-known multinationals such as Bayer AG and BASF Group, as well as prominent Indian firms, preyed on bank programs designed to raise health standards for India's poor, the report alleges, while the bank's own officials often looked the other way.
Bayer, based in Leverkusen, Germany, and BASF, based in Ludwigshafen, Germany, said they have launched internal inquiries into allegations that their Indian subsidiaries participated in a bid-rigging cartel involving some $33 million in procurements of a mosquito pesticide called pyrethroid.
The World Bank report also said Aventis CropScience and Zeneca Agrochemicals Ltd. are suspected of belonging to the cartel, which the report says existed from 1999 to 2004. A spokesman for Zeneca, of Basel, Switzerland, now called Syngenta International AG, had no comment. Aventis, now Sanofi Aventis SA of Paris, said it had no comment because its crop-science unit is now owned by Bayer.
The long-awaited India report found numerous signs of fraud, such as funding to aid groups that didn't exist, suspicious bidding practices and substandard equipment. Officials at both the bank and the government of India were aware of these matters but failed to act, the report states. World Bank President Robert Zoellick said the bank is "committed to getting to the bottom of how these problems occurred."
In the malaria program, the report says investigators discovered that the four European firms won 18 out of the first 21 bidding competitions using "identical or unusually similar bid prices" and other "unusual patterns." The contract awards appeared to be rotated among the companies and sometimes divided among them.
Pyrethroids are synthetic chemical compounds used in mosquito netting to kill mosquito larvae, which helps prevent transmission of malaria and the West Nile virus.
The report's findings are preliminary and will lead to further investigation by the World Bank before any sanctions. But the report notes that in other debarment cases, the bank's Sanctions Board found the use of identical prices in procurement cases to be "particularly compelling" evidence of collusion. It is unclear whether debarment by the World Bank -- which typically lasts three to five years -- would materially damage any of the companies in terms of revenue, but the hit to their reputations could be severe and prompt additional legal fallout both in their home jurisdictions and other countries.
The government of India says it is also taking corrective action on the pyrethroid affair and other aspects of the voluminous report, which delves into national AIDS, malaria and tuberculosis control projects as well as the health system in the Indian state Orissa...
The full article is available with subscription at: http://online.wsj.com/article/SB120097391278105825.html?mod=googlenews_wsj
If you would like to request a copy, please submit the title, date and publication through our Contact page.